Compound Profiles
BPC-157
Body Protection Compound-157 | Pentadecapeptide
Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..
Naltrexone
Opioid Antagonist | Low-Dose Anti-Inflammatory & Immune Modulation
At low doses (1-4.5 mg), naltrexone produces a brief nocturnal blockade of opioid receptors that lasts approximately 4-6 hours.
Combined Organ Load
Frequently Asked Questions
Can I take BPC-157 with Naltrexone?
Yes, BPC-157 and Naltrexone can generally be taken together. BPC-157 reduces inflammation while Naltrexone promotes tissue repair. Reducing inflammation creates a more favorable environment for healing.
Is BPC-157 and Naltrexone safe together?
Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.
What are the interactions between BPC-157 and Naltrexone?
BPC-157 reduces inflammation while Naltrexone promotes tissue repair. Reducing inflammation creates a more favorable environment for healing. This assessment has 50% confidence and is inferred from pharmacological mechanism analysis.
How should I time BPC-157 and Naltrexone?
BPC-157 has a half-life of <30 minutes and Naltrexone has a half-life of ~4 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.